1.23 USD
▲-0.01+6.03%
2026-08-03
市值
$3.27M
市盈率
—
EPS
-7.92
股息率
—
52 周区间
1.05 – 8.62
成交量
87.70K
Beta
2.47
目标价
3.70
52W 低 1.0552W 高 8.62
价格走势
公司简介
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal and pneumocystis pneumonias, and candidiasis disease; and Celgosivir for Zi...